Research Topics
Species | J Eric AhlskogSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
Benign tremulous parkinsonismKeith A Josephs
Division of Movement Disorders, Department of Neurology, Mayo Clinic, Rochester, Minn, USA
Arch Neurol 63:354-7. 2006..Benign tremulous parkinsonism has never been precisely defined nor has the long-term course been studied...
Early-onset familial parkinsonism due to POLG mutationsGuido Davidzon
Department of Neurology, Columbia University Medical Center, New York, NY 10032, USA
Ann Neurol 59:859-62. 2006..INTERPRETATION: POLG mutations can cause early-onset parkinsonism in the absence of progressive external ophthalmoplegia...
Cheaper, simpler, and better: tips for treating seniors with Parkinson diseaseJ Eric Ahlskog
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 86:1211-6. 2011..A dozen tips for optimizing treatment of Parkinson disease are discussed herein...
Does vigorous exercise have a neuroprotective effect in Parkinson disease?J Eric Ahlskog
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Neurology 77:288-94. 2011..3) Levodopa and other forms of dopamine replenishment therapy should be utilized to achieve the maximum capability and motivation for patients to maintain fitness...
Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's diseaseJ Eric Ahlskog
Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA
Mov Disord 20:271-82. 2005..Although the clinical and therapeutic importance of the nigrostriatal dopaminergic system is undeniable, PD neuropathology is much more widespread...
Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's diseaseJ Eric Ahlskog
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Parkinsonism Relat Disord 15:721-7. 2009..Although sporadic PD is also associated with mitochondrial dysfunction, Lewy neurodegeneration represents a more pervasive disorder with perhaps a second, or different primary mechanism...
Pearls: parkinsonismJ Eric Ahlskog
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA
Semin Neurol 30:10-4. 2010..g., fatigue, depression, insomnia, pain, stiffness). Many subtle clues provided by history and examination are crucial, with laboratory and imaging being primarily supportive...
Parkinson's disease: is the initial treatment established?J Eric Ahlskog
Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Curr Neurol Neurosci Rep 3:289-95. 2003..Carbidopa/levodopa, pramipexole, and ropinirole are all appropriate first choices in the treatment of PD...
Physical exercise as a preventive or disease-modifying treatment of dementia and brain agingJ Eric Ahlskog
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 86:876-84. 2011..Exercise should not be overlooked as an important therapeutic strategy...
Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?J Eric Ahlskog
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Neurology 74:1143-8. 2010..These studies further illustrate the difficulty in documenting a disease-modifying effect when considering a PD drug with symptomatic benefit...
Slowing Parkinson's disease progression: recent dopamine agonist trialsJ Eric Ahlskog
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Neurology 60:381-9. 2003..To date, there is no compelling evidence favoring dopamine agonists over levodopa; either is an appropriate choice for initial treatment of PD...
Beating a dead horse: dopamine and Parkinson diseaseJ Eric Ahlskog
Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Neurology 69:1701-11. 2007..Finally, the benefits from transplantation surgeries aimed at restoring dopaminergic neurotransmission will be limited because later-stage PD disability comes from nondopaminergic substrates. Scale...
Pathological behaviors provoked by dopamine agonist therapy of Parkinson's diseaseJ Eric Ahlskog
Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, United States
Physiol Behav 104:168-72. 2011..This experience points to the dopamine D3 receptor as a potential therapeutic target for gambling, sex or other addictions occurring spontaneously in the general population...
Risk of cognitive impairment or dementia in relatives of patients with Parkinson diseaseWalter A Rocca
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
Arch Neurol 64:1458-64. 2007..The evidence for increased risk of dementia in relatives of patients with Parkinson disease (PD) remains conflicting...
Neuropathology of non-motor features of Parkinson diseaseDennis W Dickson
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 15:S1-5. 2009....
Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort studyAlexis Elbaz
Departments of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Mov Disord 20:719-25. 2005..Among PD patients, there was no relation between the risk of cancer and the cumulative dose of levodopa received or the use of other PD medications...
Increased risk of essential tremor in first-degree relatives of patients with Parkinson's diseaseWalter A Rocca
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Mov Disord 22:1607-14. 2007..These findings suggest that PD and ET may share familial susceptibility factors...
Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family StudyShannon K McDonnell
Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Ann Neurol 59:788-95. 2006..The best fitting models for older onset PD (age > 59 years) were a recessive or an additive model. INTERPRETATION: The familial aggregation of PD may be explained in part by a major gene with additive effect on the penetrance...
Comparison of risk factor profiles in incidental Lewy body disease and Parkinson diseaseRoberta Frigerio
Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55902, USA
Arch Neurol 66:1114-9. 2009..To explore whether associations of potential risk factors for incidental Lewy body disease (iLBD) are similar to those for Parkinson disease (PD)...
Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's diseaseHiroshige Fujishiro
Department of Pathology Neuropathology, Mayo Clinic, Jacksonville, Florida, USA
Mov Disord 23:1085-92. 2008..42, P < 0.05). This study demonstrates that cardiac sympathetic degeneration and alpha-synuclein pathology is present in presymptomatic phase of PD, and that both increase with disease duration and severity...
Chemical exposures and Parkinson's disease: a population-based case-control studyRoberta Frigerio
Division of Epidemiology, Department of Health Sciences Research, Mayo College of Medicine, Rochester, Minnesota 55905, USA
Mov Disord 21:1688-92. 2006..This population-based study suggests a link between pesticides use and PD that is restricted to men. Pesticides may interact with other genetic or nongenetic factors that are different in men and women...
Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?Roberta Frigerio
Department of Neurology, Mayo Clinic, Rochester, MN, United States
Neurobiol Aging 32:857-63. 2011....
Incidental Lewy body disease and preclinical Parkinson diseaseAnthony DelleDonne
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
Arch Neurol 65:1074-80. 2008..The significance of Lewy bodies detected at autopsy in the brains of clinically normal individuals is uncertain but may represent preclinical Parkinson disease (PD)...
Number of children and risk of Parkinson's diseaseRoberta Frigerio
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Mov Disord 22:632-9. 2007..The independent replication in two distinct populations and using different epidemiologic study designs may suggest a link between the number of children and PD restricted to men...
The Mayo Clinic family study of Parkinson's disease: study design, instruments, and sample characteristicsWalter A Rocca
Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minn, USA
Neuroepidemiology 24:151-67. 2005..Finally, we studied a group of 625 spouses of either cases or controls. Relatives with PD or other neurodegenerative diseases were ascertained using the family study method...
Whole-body tremulousness: isolated generalized polymyoclonusAndrew McKeon
Department of Neurology, Gonda 8 South, Mayo Clinic, 200 First St SW, Rochester, MN 55902, USA
Arch Neurol 64:1318-22. 2007..Acquired generalized repetitive myoclonus may be mistaken for tremor. Distinguishing myoclonus has etiologic and therapeutic implications...
Psychogenic tremor: long-term prognosis in patients with electrophysiologically confirmed diseaseAndrew McKeon
Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Mov Disord 24:72-6. 2009..037). Physiologically-confirmed psychogenic tremor carries a poor prognosis, with unremitting or worse tremor persisting 3-years after diagnosis in most...
Parkinsonism and dropped head: dystonia, myopathy or both?Rodolfo Savica
Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
Parkinsonism Relat Disord 18:30-4. 2012..The substrate for DHS is controversial, with some concluding that the cause is myopathic and others, exclusively dystonic. We report our clinical series of DHS arising in the setting of parkinsonism...
Deep brain stimulation in benign tremulous parkinsonismRodolfo Savica
Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
Arch Neurol 68:1033-6. 2011..This disorder has an uncertain pathophysiologic relationship to idiopathic Parkinson disease. Deep brain stimulation (DBS) should be efficacious for this condition, but there is no previously published experience...
Orthostatic myoclonus: a contributor to gait decline in selected elderlyGraham A Glass
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Neurology 68:1826-30. 2007..We encountered 15 patients with a newly recognized clinical phenomenon that we term orthostatic myoclonus. We conducted a retrospective chart review to better understand the clinical context and importance of this phenomenon...
Anxious personality predicts an increased risk of Parkinson's diseaseJames H Bower
Department of Neurology, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Mov Disord 25:2105-13. 2010..Our long-term historical cohort study suggests that an anxious personality trait may predict an increased risk of PD developing many years later...
Metabolic markers or conditions preceding Parkinson's disease: a case-control studyRodolfo Savica
Department of Neurology, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Mov Disord 27:974-9. 2012..77; 95% CI, 0.37-1.57; P = .47). Our study, based on historical information from a records-linkage system, does not support an association between BMI, cholesterol level, hypertension, or diabetes mellitus with later development of PD...
Rapidly progressive neurodegenerative dementiasKeith A Josephs
Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Arch Neurol 66:201-7. 2009..Neurodegenerative dementias are typically characterized by an insidious onset and a relatively slowly progressive course. Less common are patients with a rapidly progressive course to death...
Familial aggregation of Parkinson's disease: The Mayo Clinic family studyWalter A Rocca
Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Ann Neurol 56:495-502. 2004..62; 95% confidence interval, 1.66-4.15), whereas relatives of probands with later onset had no increased risk. The relative risk decreased when the incidence of all types of parkinsonism was considered...
Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990Jay A Van Gerpen
Department of Neurology, Ochsner Clinic, New Orleans, LA, USA
Arch Neurol 63:205-9. 2006..This population-based study suggests dyskinesia risk may not be a major concern for most Parkinson disease patients...
Interaction of alpha-synuclein and tau genotypes in Parkinson's diseaseCatherine E Mamah
Department of Neurology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Ann Neurol 57:439-43. 2005..These findings are consistent with in vitro experiments that revealed tau-mediated fibrillization of alpha-synuclein protein at low concentrations (dose threshold effect)...
Stiff-man syndrome and variants: clinical course, treatments, and outcomesAndrew McKeon
Department of Neurology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
Arch Neurol 69:230-8. 2012..Little information is available about the incidence of stiff-man syndrome (SMS) (the classic form or its variants) or about long-term treatment responses and outcomes...
Survival study of Parkinson disease in Olmsted County, MinnesotaAlexis Elbaz
Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
Arch Neurol 60:91-6. 2003..CONCLUSIONS: Patients with PD face a higher risk of death compared with subjects free of PD from the general population. Certain clinical characteristics and smoking modify survival...
Acquired hypocupremia after gastric surgeryNeeraj Kumar
Department of Neuroogy, Mayo Clinic, Rochester, Minnesota 55905, USA
Clin Gastroenterol Hepatol 2:1074-9. 2004..Acquired copper deficiency is not a well-recognized complication of gastric surgery. In Menke's disease a defect in enterocyte transport of absorbed copper results in increased copper content in the duodenal mucosa and hypocupremia...
Levodopa-dyskinesia incidence by age of Parkinson's disease onsetNeeraj Kumar
Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA
Mov Disord 20:342-4. 2005..With onset from 40 to 59 years of age, the incidence was higher at 50%. These incidence data may overestimate the functional importance, because patients with minimal or reversible dyskinesias were counted...
The Mayo Clinic cohort study of personality and aging: design and sampling, reliability and validity of instruments, and baseline descriptionWalter A Rocca
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Neuroepidemiology 26:119-29. 2006..68, p < 0.0001). This newly established historical cohort study provides opportunities to test hypotheses regarding the link between personality and aging, aging-related diseases, and overall mortality...
UCHL1 is associated with Parkinson's disease: a case-unaffected sibling and case-unrelated control studyMaurizio Facheris
Department of Neurology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Neurosci Lett 381:131-4. 2005..Analyses confirmed a significant inverse association of the UCHL1 S18Y polymorphism with PD overall (OR=0.18, 95% CI=0.05-0.64, p=0.002, recessive model) and in several strata...
When does Parkinson disease start?Rodolfo Savica
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
Arch Neurol 67:798-801. 2010..Recognition of a nonmotor preclinical phase spanning 20 or more years should guide the search for predictive biomarkers and the identification of risk or protective factors for Parkinson disease...
Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathwayTimothy G Lesnick
Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America
PLoS ONE 3:e1449. 2008..We also demonstrated that several axon guidance pathway genes represented by SNPs within our final models were differentially expressed in PD...
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophyKevin J Klos
Department of Neurology, Division of Movement Disorders, Mayo Clinic, Rochester, MN 55905, USA
Parkinsonism Relat Disord 11:381-6. 2005..A systematic literature review of pathological hypersexuality in PD revealed similar medication histories; combining these cases with our series, 26 of 29 patients (90%) were on adjuvant dopamine agonists...
Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?Joanna M Biernacka
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55095, USA
Parkinsonism Relat Disord 17:730-6. 2011..Here we investigated the association of PD with interactions between variants of these genes...
Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function testsValeria Iodice
Neurovascular and Autonomic Medicine Unit, Imperial College London, UK
J Neurol Neurosurg Psychiatry 83:453-9. 2012..Published autopsy confirmed cases have provided reasonable neurological characterisation but have lacked adequate autonomic function testing...
Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson diseaseGennarina Arabia
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Arch Gen Psychiatry 64:1385-92. 2007..Relatives of patients with Parkinson disease (PD) have an increased risk of PD and other neurologic disorders; however, their risk of psychiatric disorders remains uncertain...
Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance imagesAndrew McKeon
Department of Neurology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
Arch Neurol 66:268-71. 2009..To describe reversible extralimbic paraneoplastic encephalopathies with large, lobar lesions on magnetic resonance imaging (MRI)...
Dopamine agonists and Othello's syndromeJonathan Graff-Radford
Department of Neurology, Mayo Clinic, 200 1st Street SW Rochester, MN 55905, USA
Parkinsonism Relat Disord 16:680-2. 2010..Othello's syndrome (OS) is a delusion of infidelity. We describe seven cases of OS in Parkinson's disease (iPD) patients using dopamine agonists...
Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failureAxel Lipp
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Arch Neurol 66:742-50. 2009....
The spectrum of disorders presenting as adult-onset focal lower extremity dystoniaAndrew McKeon
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Parkinsonism Relat Disord 14:613-9. 2008..Uncommonly, adult-onset dystonia is confined to one lower extremity. We sought to characterize the clinical spectrum associated with the presenting phenotype of lower limb dystonia including foot torsion...
Genetic susceptibility loci, environmental exposures, and Parkinson's disease: A case-control study of gene-environment interactionsSun Ju Chung
Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea Department of Neurology, Mayo Clinic, Rochester, MN, USA
Parkinsonism Relat Disord 19:595-9. 2013..Here we investigated the interactions between SNPs in those three susceptibility genes and environmental exposures (pesticides application, tobacco smoking, coffee drinking, and alcohol drinking) also associated with PD susceptibility...
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's diseaseDennis W Dickson
Neuropathology Laboratory, Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Acta Neuropathol 115:437-44. 2008..The findings suggest that iLBD is preclinical PD and that the lack of symptoms is due to subthreshold pathology...
Copper deficiency myelopathy produces a clinical picture like subacute combined degenerationNeeraj Kumar
Department of Neurology, Mayo Clinic, Rochester, MN, USA
Neurology 63:33-9. 2004..Copper deficiency in ruminants is known to cause an ataxic myelopathy. Copper deficiency as a cause of progressive myelopathy in adults is underrecognized...
Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementiaWilliam T Hu
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Alzheimer Dis Assoc Disord 21:S39-43. 2007..In summary, survival in 4R tauopathies seemed independent of the presenting clinical phenotype, and there may be subtle clinical differences between bv-FTD patients with 3R and 4R tauopathies...
Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson diseaseJ Michael Bostwick
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 84:310-6. 2009..To determine the frequency of new-onset compulsive gambling or hypersexuality among regional patients with Parkinson disease (PD), ascertaining the relationship of these behaviors to PD drug use...
A genomic pathway approach to a complex disease: axon guidance and Parkinson diseaseTimothy G Lesnick
Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America
PLoS Genet 3:e98. 2007..This genomic pathway approach may also offer insights into other complex diseases such as Alzheimer disease, diabetes mellitus, nicotine and alcohol dependence, and several cancers...
Nonfatal cancer preceding Parkinson's disease: a case-control studyAlexis Elbaz
Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
Epidemiology 13:157-64. 2002..There were suggestive trends in analyses stratified by sex and age at onset of PD, and for specific cancers related to smoking or hormonal factors...
Focal brain atrophy in gastric bypass patients with cognitive complaintsJonathan Graff-Radford
Department of Neurology Behavioral Neurology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
J Clin Neurosci 18:1671-6. 2011..Patients with cognitive complaints after gastric bypass surgery may have focal thalamic brain atrophy that could result in cognitive impairment...
High school football and risk of neurodegeneration: a community-based studyRodolfo Savica
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 87:335-40. 2012..To assess whether high school football played between 1946 and 1956, when headgear was less protective than today, was associated with development of neurodegenerative diseases later in life...
Pathological gambling caused by drugs used to treat Parkinson diseaseM Leann Dodd
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA
Arch Neurol 62:1377-81. 2005..Pathological gambling is a rare potential complication related to treatment of Parkinson disease (PD). However, the etiology of this behavior is poorly understood...
Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicityKevin J Klos
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Arch Neurol 62:1385-90. 2005..We selected cases on the basis of evidence of brain manganese accumulation, and this may be a crucial component of these syndromes. Further studies are necessary to explore this issue...
Limb immobilization and corticobasal syndromeJonathan Graff-Radford
Department of Neurology, Behavioral Neurology, Mayo Clinic, Rochester, MN 55905, USA
Parkinsonism Relat Disord 18:1097-9. 2012..Recently, we evaluated two patients with corticobasal syndrome (CBS) who reported symptom onset after limb immobilization. Our objective was to investigate the association between trauma, immobilization and CBS...
Imaging features of copper deficiency myelopathy: a study of 25 casesNeeraj Kumar
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Neuroradiology 48:78-83. 2006..Neuroradiologists should consider this possibility when a long segment of symmetric dorsal spinal cord T2-hyperintensity is identified...
Psychogenic tremor occurring after deep brain stimulation surgery for essential tremorAndrew McKeon
Department of Neurology, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA
Neurology 70:1498-9. 2008
Risk tables for parkinsonism and Parkinson's diseaseAlexis Elbaz
Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
J Clin Epidemiol 55:25-31. 2002..Lifetime risk estimates are useful in clinical practice, epidemiologic research, and public health...
"Myelodysplasia," myeloneuropathy, and copper deficiencyNeeraj Kumar
Department of Neurology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 80:943-6. 2005..The hematologic picture can resemble sideroblastic anemia or myelodysplastic syndrome. Hyperzincemia can be an accompanying abnormality even without exogenous zinc ingestion. The reason for the copper deficiency may not be evident...
Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo ClinicAaron A Cohen-Gadol
Department of Neurologic Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
J Neurosurg 98:1247-54. 2003..The authors assessed preoperative factors to determine which, if any, correlated with outcomes in patients with torticollis who had undergone this procedure...
Myelopathy due to copper deficiencyNeeraj Kumar
Department of Neurology, Mayo Clinic, Rochester, MN, USA
Neurology 61:273-4. 2003
Myelopathy due to copper deficiency following gastrointestinal surgeryNeeraj Kumar
Department of Neurology, Mayo Clinic, Rochester, Minn 55905, USA
Arch Neurol 60:1782-5. 2003..The neurological consequences of acquired copper deficiency in humans are not well described...
Copper deficiency myelopathyNeeraj Kumar
Department of Neurology, Mayo Clinic, Mayo Foundation, Rochester, Minn, USA
Arch Neurol 61:762-6. 2004..Myelopathy due to acquired copper deficiency is not a well-recognized entity in humans, although myelopathy due to copper deficiency is well documented in some animal species...
Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysmBahram Mokri
Department of Neurology, Mayo Clinic, Rochester, MN, USA
Neurology 62:971-3. 2004..The latent and progressive phase closely resembled a progressive supranuclear palsy phenotype. The disorder may prove to be self-limiting but leaves the patients with considerable neurologic deficits...
Normal pressure hydrocephalus: how often does the diagnosis hold water?Bryan T Klassen
Department of Neurology, Mayo Clinic Rochester, 200 First Street SW, Rochester, MN 55905, USA
Neurology 77:1119-25. 2011..To determine our community's incidence of clinically suspected normal pressure hydrocephalus (NPH), the rate of shunting for NPH, and short- and long-term outcomes of shunting...
Chorea as a manifestation of spontaneous CSF leakBahram Mokri
Department of Neurology, E8A, Mayo Clinic College of Medicine, 200 First Street S W, Rochester, MN 55905, USA
Neurology 67:1490-1. 2006..CSF pressure was low. CT myelography documented CSF leak at the cervicothoracic junction. Targeted epidural blood patch led to resolution of symptoms, including complete disappearance of choreiform movements...
Respiratory insufficiency as the primary presenting symptom of multiple-system atrophyGraham A Glass
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Arch Neurol 63:978-81. 2006..Otherwise unexplained central respiratory failure, bilateral vocal cord paralysis, stridor, or refractory central sleep apnea should prompt consideration of MSA...
Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunctionSean J Pittock
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Mayo Clin Proc 81:1207-14. 2006..To describe novel neurological manifestations associated with glutamic acid decarboxylase (GAD65) autoimmunity...
Antiphospholipid antibody-associated choreaNicole M Orzechowski
Division of Rheumatology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
J Rheumatol 35:2165-70. 2008..To describe the clinical features, treatment, and outcomes of patients with antiphospholipid antibody (aPL)-associated chorea...
Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathologySean J Pittock
Department of Neurology Mayo Clinic, Rochester, Minnesota 55905, USA
Mov Disord 19:695-9. 2004..The absence of diagnostic microscopic brain or spinal cord pathology suggests that the pathologic substrate may be neurochemical or receptor based...
MRI correlates of alien leg-like phenomenon in corticobasal degenerationWilliam T Hu
Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA
Mov Disord 20:870-3. 2005..The MRI brain scan in both had unique focal abnormalities in the corresponding leg area of the homunculus that may be the substrate for the alien limb features...
Parkinson disease neuropathology: later-developing dementia and loss of the levodopa responseHulya Apaydin
Department of Neurology, Istambul University, , Turkey
Arch Neurol 59:102-12. 2002..The occurrence of Alzheimer pathology was modest, but was highly correlated with Lewy body pathology, suggesting common origins or one triggering the other...
Brain imaging to assess the effects of dopamine agonists on progression of Parkinson diseaseJ Eric Ahlskog
JAMA 288:311; author reply 312-3. 2002
Myelopolyneuropathy due to copper deficiency or zinc excess?Neeraj Kumar
Arch Neurol 61:604-5; author reply 605. 2004
I can't get no satisfaction: still no neuroprotection for Parkinson diseaseJ Eric Ahlskog
Neurology 69:1476-7. 2007
